We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Recommends Gilead’s Harvoni for Two Hepatitis C Genotypes
NICE Recommends Gilead’s Harvoni for Two Hepatitis C Genotypes
The UK’s healthcare cost watchdog today gave a positive nod to Gilead Sciences’ hepatitis C combination therapy Harvoni for certain genotype 1 and 4 patients.